Correlation Between Assembly Biosciences and Unicycive Therapeutics
Can any of the company-specific risk be diversified away by investing in both Assembly Biosciences and Unicycive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assembly Biosciences and Unicycive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assembly Biosciences and Unicycive Therapeutics, you can compare the effects of market volatilities on Assembly Biosciences and Unicycive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assembly Biosciences with a short position of Unicycive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assembly Biosciences and Unicycive Therapeutics.
Diversification Opportunities for Assembly Biosciences and Unicycive Therapeutics
-0.01 | Correlation Coefficient |
Good diversification
The 3 months correlation between Assembly and Unicycive is -0.01. Overlapping area represents the amount of risk that can be diversified away by holding Assembly Biosciences and Unicycive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Unicycive Therapeutics and Assembly Biosciences is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assembly Biosciences are associated (or correlated) with Unicycive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Unicycive Therapeutics has no effect on the direction of Assembly Biosciences i.e., Assembly Biosciences and Unicycive Therapeutics go up and down completely randomly.
Pair Corralation between Assembly Biosciences and Unicycive Therapeutics
Given the investment horizon of 90 days Assembly Biosciences is expected to generate 4.97 times less return on investment than Unicycive Therapeutics. But when comparing it to its historical volatility, Assembly Biosciences is 1.92 times less risky than Unicycive Therapeutics. It trades about 0.02 of its potential returns per unit of risk. Unicycive Therapeutics is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 45.00 in Unicycive Therapeutics on August 31, 2024 and sell it today you would earn a total of 24.00 from holding Unicycive Therapeutics or generate 53.33% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Assembly Biosciences vs. Unicycive Therapeutics
Performance |
| Timeline |
| Assembly Biosciences |
| Unicycive Therapeutics |
Assembly Biosciences and Unicycive Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Assembly Biosciences and Unicycive Therapeutics
The main advantage of trading using opposite Assembly Biosciences and Unicycive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assembly Biosciences position performs unexpectedly, Unicycive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Unicycive Therapeutics will offset losses from the drop in Unicycive Therapeutics' long position.| Assembly Biosciences vs. Spero Therapeutics | Assembly Biosciences vs. Achilles Therapeutics PLC | Assembly Biosciences vs. Instil Bio | Assembly Biosciences vs. CytomX Therapeutics |
| Unicycive Therapeutics vs. Cue Biopharma | Unicycive Therapeutics vs. Eliem Therapeutics | Unicycive Therapeutics vs. Inhibrx | Unicycive Therapeutics vs. Molecular Partners AG |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Other Complementary Tools
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon |